TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
93 hedge funds and large institutions have $74.7M invested in TCR2 Therapeutics Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 35 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
66% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 41
90% less call options, than puts
Call options by funds: $7K | Put options by funds: $69K
Holders
93
Holding in Top 10
2
Calls
$7K
Puts
$69K
Top Buyers
| 1 | +$8.28M | |
| 2 | +$1.52M | |
| 3 | +$1.28M | |
| 4 |
D.E. Shaw & Co
New York
|
+$990K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$685K |
Top Sellers
| 1 | -$3.89M | |
| 2 | -$3.72M | |
| 3 | -$2.8M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.63M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$952K |